Fertility Clock Headlines, Fertility Headlines

The Sleeper STD You’re at Risk For

Politics aside, there has been one undeniable upside to the Affordable Care Act: no-cost screenings for STDs (like chlamydia, gonorrhea, and HPV) for women with an increased risk of infection. (Usually this means sexually active woman age 25 or younger.) The downside: More than half of Americans still aren’t getting these critical sexual health services, according to the National Coalition for Sexual Health.

Fertility Clock Headlines, Fertility Headlines

Study: HPV Found in Sperm; polyDNA Recommends Gene-Eden-VIR Against the Latent HPV

HPV has been found in the sperm of infected men. This can harm a man’s ability to have children. This is particularly true in those who have both HPV (human papillomavirus), which is the most common sexually transmitted viral disease (STD), and Chlamydia trachomatis (Ct), which is the most common bacterial STD.

Fertility Clock Headlines, Fertility Headlines

Two Doses of HPV Vaccine May be Just as Effective as Three, Study Shows

The human papilloma virus (HPV) vaccine is widely viewed as an effective way to protect women from both cervical cancer and genital warts.  But doctors suspect the high cost and inconvenience associated with the vaccine, which consist of three shots given over the course of six months, may be preventing women and young girls from receiving it.

Fertility Clock Headlines, Fertility Headlines

False-negative results found in HPV testing

HPV TestPHOENIX — More than 12,000 women in the United States will be diagnosed with cervical cancer this year. Hundreds more may go undiagnosed because of the widespread use of a screening test that the Food and Drug Administration has not approved for detecting the human papillomavirus, or HPV, which causes nearly all cervical cancers.

Some of the largest national labs have for a decade routinely used test kits that contain a preservative, BD SurePath, that is approved for Pap tests but not HPV testing. The labs continue to use the tests despite an FDA warning June 8 that HPV tests using SurePath can produce false negatives and national guidelines that call for using only FDA-approved tests, an Arizona Republic investigation has found.

The result: Women may be told they are free of HPV when, in fact, they aren’t. Such a misdiagnosis can allow the virus or cancer to become established and more difficult to treat. Read full article.